Emergent BioSolutions Inc. Common Stock (NY:EBS)

7.090 +0.420 (+6.30%)

Official Closing Price Updated: 7:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

September 12, 2024

From Emergent BioSolutions

Via GlobeNewswire

Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 09, 2024

Via Benzinga

Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

September 03, 2024

New favorable terms position Emergent for sustainable, long-term growth, as part of its multi-year plan to stabilize, turnaround and transform the company

From Emergent BioSolutions

Via GlobeNewswire

(EBS) - Analyzing Emergent BioSolutions's Short Interest ↗

August 20, 2024

Via Benzinga

7 Analysts Assess Emergent BioSolutions: What You Need To Know ↗

August 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 02, 2024

Via Benzinga

Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine ↗

August 30, 2024

Emergent BioSolutions stock jumped early Friday.

Via Investor's Business Daily

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

August 30, 2024

From Emergent BioSolutions

Via GlobeNewswire

Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection ↗

August 30, 2024

The FDA has approved Emergent BioSolutions' supplemental Biologics License Application for ACAM2000 to include the prevention of mpox disease in high-risk individuals, with the approval based on human...

Via Benzinga

Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

August 30, 2024

Via Benzinga

Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions

August 29, 2024

From Emergent BioSolutions

Via GlobeNewswire

WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped' ↗

August 26, 2024

To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.

Via Benzinga

Macy's Reports Weak Sales, Joins JD.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 21, 2024

Via Benzinga

Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

August 20, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

August 19, 2024

From Emergent BioSolutions

Via GlobeNewswire

3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge ↗

August 19, 2024

Mpox rerun is making these stocks soar. But a non-vaccine approach could yield greater gains.

Via Talk Markets

Why Emergent BioSolutions Stock Is Skyrocketing Today ↗

August 16, 2024

Concerns about the mpox outbreak are causing Emergent BioSolutions' shares to jump.

Via The Motley Fool

H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday ↗

August 16, 2024

Via Benzinga

Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗

August 16, 2024

Via Benzinga

Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On? ↗

August 15, 2024

Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa.

Via Benzinga

Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session ↗

August 15, 2024

Via Benzinga

WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak ↗

August 14, 2024

A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fighting the virus.

Via Benzinga

Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks ↗

August 07, 2024

Emergent BioSolutions reported Q2 2024 sales of $254.7 million, beating estimates but showing a 25% decline year-over-year. Despite a significant adjusted EPS loss and mixed performance across product...

Via Benzinga

Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 07, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 07, 2024

Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!

Via InvestorPlace

Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

August 07, 2024

Via Benzinga

Emergent BioSolutions (EBS) Q2 2024 Earnings Call Transcript ↗

August 07, 2024

EBS earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Emergent BioSolutions Reports Second Quarter 2024 Financial Results

August 06, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country

August 06, 2024

From Emergent BioSolutions

Via GlobeNewswire

8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803% ↗

August 01, 2024

Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and Q32 Bio at 101%.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.